null Results of seed funding competition in precision oncology

The RI-MUHC’s Cancer Research Program is pleased to announce the winners of Precision Oncology Hypothesis-Driven Seed Funding Competition

On February 4, the world community unites for World Cancer Day, raising awareness and working together to “Close the Care Gap” and reduce the global impact of cancer.

For this special occasion, the Cancer Research Program (CRP) of the RI-MUHC is pleased to announce the winners of the second edition of its Precision Oncology Hypothesis-Driven Seed Funding Competition. Thanks to the generous donation from Bank of Montreal raised through the MUHC Foundation Dream Big: End Cancer fundraising campaign, two CRP teams will be awarded $100K each to develop new collaborative translational research projects in precision oncology.

Congratulations to this year's winners:

Alex Gregorieff and Sampath Loganathan
Project Title: Development of a CRISPR-based screening platform in patient-derived cancer organoids.

Wassim Kassouf and Ciriaco Piccirillo
Project Title: Sex-Specific Responses to Radiation Therapy in Muscle Invasive Bladder Cancer: The Function of Tumor-Infiltrating B Cells in Treatment Outcomes

Researchers interested in more information about this competition are invited to contact

February 4, 2024

World Cancer Day